Invex Therapeutics Ltd.ASX: IXC

Invex to Acquire Rekover Therapeutics

· Issued by Invex Therapeutics Ltd. via ASX

Filed with ASX · · 8 pages · English

Summary by 6ix AI

Invex Therapeutics Ltd. has announced its intention to acquire Rekover Therapeutics, a New Zealand biotechnology company, through a binding share sale and purchase agreement. The acquisition involves issuing shares and performance rights contingent on achieving specific milestones related to a clinical study for treating multiple sclerosis.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/invex-to-acquire-rekover-therapeutics

Release

ASX / Media Release 26 October 2026 Invex to Acquire Rekover Therapeutics Highlights • Invex has entered into a binding share sale and purchase agreement (Share Purchase Agreement) to acquire 100% of the issued share capital of Rekover Therapeutics Limited (Rekover), a New Zealand biotechnology...

Invex Therapeutics Ltd. on 6ix

Earlier from Invex Therapeutics

All Invex Therapeutics news releases